Biophysical and Structural Biology Methods Enable Fragment-Based Ligand Discovery

November 15, 2023
8:00 a.m. PST / 11:00 a.m. EST / 16:00 GMT / 17:00 CET - Duration: 60 Minutes


Powerful biophysical and structural biology tools enable the study of large numbers of fragments and are opening up new possibilities in the treatment of various diseases. Here we report the results of a conventional and a covalent Fragment Screening and show how orthogonal biophysical and structural methods enable rapid identification, characterization, and optimization of fragments. 

Key Learning Objectives:
  • Covalent & Conventional FBDD as an Integrated Service in Wuxi Biology
  • Available Fragment Libraries
  • Established Screening Workflow & Screening Technologies
  • Structure Determination for Fragments
  • Hit Expansion & Med Chem Capabilities
  • Case Studies to Highlight Capabilities
Who Should Attend:
  • CSO, Senior Scientist, MedChem experts & all scientist interested in FBDD as well as discovery of covalent inhibitors

Brought to you by:
WuXi AppTec Logo


Moran Jerabek-Willemsen, PhD
Head of Biophysics & Screening,
WuXi Biology
Catherine Dold
Health & Environment Writer,
C&EN Media Group


*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

© 2024 American Chemical Society, 1155 16th St NW, Washington, DC 20036, USA. View our Privacy Policy